• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

CTAG1B Gene Record

  • Summary
  • Interactions
  • Claims
  • CTAG1B 1485

    Alternate Names:

    1485
    CANCER/TESTIS ANTIGEN 1B
    CTAG1B
    CT6.1
    CTAG
    CTAG1
    ESO1
    LAGE-2
    LAGE2B
    NY-ESO-1
    300156
    2491
    ENSG00000184033
    OTTHUMG00000024232
    1278

    Gene Info:

    Gene Biotype PROTEIN_CODING
    (0 More Sources)

    Gene Categories: Category Details

    Publications:

    Weiser et al., Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1., J. Immunother.
  • ROMIDEPSIN   CTAG1B

    Interaction Score: 5.68

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    11265773


    Sources:
    NCI

  • Ensembl: ENSG00000184033

    • Version: 101_38

    Alternate Names:
    CTAG1B Ensembl Gene Name

    Gene Info:
    Gene Biotype PROTEIN_CODING

    Publications:

  • CIViC: CTAG1B

    • Version: 14-September-2020

    Alternate Names:
    1485 Entrez Gene ID
    1278 CIViC Gene ID

    Gene Info:

    Publications:
    Rapoport et al., 2015, NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma., Nat. Med.

  • NCI: CTAG1B

    • Version: 14-September-2017

    Alternate Names:

    Gene Info:

    Publications:
    Bownds et al., Induction of tumor-reactive cytotoxic T-lymphocytes using a peptide from NY-ESO-1 modified at the carboxy-terminus to enhance HLA-A2.1 binding affinity and stability in solution., J. Immunother.
    Weiser et al., Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1., J. Immunother.

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2021-04-13